Quarterly report pursuant to Section 13 or 15(d)

Revisions of Previously Issued Financial Statements

v3.20.2
Revisions of Previously Issued Financial Statements
3 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Revisions of Previously Issued Financial Statements

Note 9 – Revisions of Previously Issued Financial Statements

 

During the course of preparing the annual report on Form 10-K for the year ended June 30, 2020, we determined that costs incurred during the application development phase of certain new software applications and enhancements were not properly capitalized, which resulted in the overstatement of operating expenses and net loss, and an understatement of amortization expense for each of the quarters during the year ended June 30, 2020We assessed the materiality of these errors on prior periods’ financial statements and concluded that the errors were not material to any prior annual or interim periods, but the cumulative adjustments necessary to correct the errors would be material if we recorded the corrections the period in which the errors were identified. In accordance with GAAP, we are revising the prior periods’ financial statements when they are next issued. See Item. 4 of Part I, Controls, and Procedures. 

 

The tables below disclose the effects on the financial statements included in this Quarterly Report on Form 10-Q and the financial statements yet to be reissued: 

 



Three Months Ended September 30, 2019

 

 

As reported

 

Adjustment

 

As revised

  

Condensed Consolidated Statements of Operations 

 

 

 

 

 

 

  

Cost of revenue
$ 1,397,361 $ (17,660 ) $ 1,379,701
Gross profit

 


1,795,529

17,660

1,813,189

  

Product development

1,130,880
(519,978 )
610,902
Selling, general and administrative

3,583,815
17,899
3,601,714
Net loss

 


(2,846,071 )
519,739

(2,326,332 )
Net loss per share

 

 

(0.26 )




(0.21 )

Three Months Ended December 31, 2019 


As reported
Adjustment
As revised
Condensed Consolidated Statements of Operations









Cost of revenue


$ 1,638,840
$ (23,601 ) $ 1,615,239
Gross profit

1,667,363

23,601

1,690,964
Product development 

1,261,509

(638,008 )
623,501
Selling, general and administrative

4,796,404

86,768

4,883,172
Net loss

(4,338,536 )
574,841

(3,763,695 )
Net loss per share

(0.40 )


(0.34 )













Six Months Ended December 31, 2019



As reported Adjustment As revised
Condensed Consolidated Statements of Operations









Cost of revenue

 

$

3,036,201 $ (41,261 ) $ 2,994,940
Gross profit

 


3,462,892

41,261

3,504,153
Product development

2,392,389
(1,157,986 )
1,234,403
Selling, general and administrative

 


8,380,219
104,667
8,484,886
Net loss

(7,184,607 )
1,094,580

(6,090,027 )
Net loss per share

(0.66 )


(0.56 )

 

 










Three Months Ended March 31, 2020


As reported
Adjustment
As revised
Condensed Consolidated Statement of Operations









Cost of revenue
$ 1,420,909
$ (24,690 ) $ 1,396,219
Gross profit

1,649,637

24,690

1,674,327
Product development

1,632,353

(757,566 )
874,787
Selling, general and administrative 

5,500,837

177,405

5,678,242
Net loss

(5,348,980 )
604,851

(4,744,129 )
Net loss per share

(0.43 )


(0.38 )













Nine Months Ended March 31, 2020


As reported

Adjustment

As revised

Condensed Consolidated Statements of Operations









Cost of revenue
$ 4,457,110 $ (65,951 ) $ 4,391,159
Gross profit

5,112,529

65,951

5,178,480

Product development 



4,024,742
(1,915,552 )
2,109,190
Selling, general and administrative

13,881,056
282,072
14,163,128
Net loss

(12,533,587 )
1,699,431

(10,834,156 )
Net loss per share

(1.11 )


(0.96 )